# Reverie Labs

Source: https://onco.cc/companies/reverie-labs/  
OnCo record `reverie-labs` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Reverie Labs used machine learning to design cancer drugs that could cross into the brain. It is no longer operating.

## Summary

Reverie Labs was a Cambridge, Massachusetts drug discovery company that built machine-learning models for small-molecule design and applied them to brain-penetrant kinase inhibitors for cancers with central nervous system involvement. It grew to roughly 30 people and ran discovery partnerships before the YC directory marked it inactive; its website was offline when checked. Recorded as wound down; no acquirer is named because none was found in a primary source.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: yc
- HQ: Cambridge, MA
- Type: ai-software
- Website: https://www.ycombinator.com/companies/reverie-labs

## Sources

- Y Combinator profile: https://www.ycombinator.com/companies/reverie-labs

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/)
- fronts: [AI & Computation](https://onco.cc/fronts/ai-computation/), [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- technologies: [AI-driven drug & target discovery](https://onco.cc/technologies/ai-drug-design/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- companies: [Y Combinator](https://onco.cc/companies/y-combinator/)

---
JSON: https://onco.cc/api/v1/entities/reverie-labs.json